Catherine Isted

Director of Finance/CFO at SANTHERA PHARMACEUTICALS HOLDING AG

51 year

Health Technology

Finance

Technology Services

Profile

Catherine Isted currently works at Santhera Pharmaceuticals Holding AG, as Chief Financial Officer from 2025.
Ms. Isted also formerly worked at ReNeuron Group Plc, as Chief Executive Officer & Executive Director from 2022 to 2023, Oxford Biomedica Plc, as Head-Corporate Development & Investor Relations from 2019 to 2021, Nomura Code Securities Ltd., as Sales Associate from 2009 to 2013, Peel Hunt LLP, as Sales Associate from 2015 to 2019, and BenevolentAI SA, as Chief Financial Officer from 2023 to 2024.

Catherine Isted active positions

Companies	Position	Start
SANTHERA PHARMACEUTICALS HOLDING AG	Director of Finance/CFO	24/02/2025

All active positions of Catherine Isted

Former positions of Catherine Isted

Companies	Position	End
BENEVOLENTAI S.A.	Director of Finance/CFO	03/07/2024
RENEURON GROUP PLC	Chief Executive Officer	03/01/2023
OXFORD BIOMEDICA PLC	Public Communications Contact	01/10/2021
Peel Hunt LLP Peel Hunt LLP Investment Banks/BrokersFinance Provides brokerage services	Sales & Marketing	01/01/2019
Nomura Code Securities Ltd. Nomura Code Securities Ltd. Investment ManagersFinance Provides advisory, fundraising, and broking services	Analyst-Equity	17/07/2009

See the detail of Catherine Isted's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Catherine Isted's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
ReNeuron Group Plc ReNeuron Group Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and manufactures cell-based therapy products	Health Technology
Oxford Biomedica Plc Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields	Health Technology
Santhera Pharmaceuticals Holding AG Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases	Health Technology
Nomura Code Securities Ltd. Nomura Code Securities Ltd. Investment ManagersFinance Provides advisory, fundraising, and broking services	Finance
Peel Hunt LLP Peel Hunt LLP Investment Banks/BrokersFinance Provides brokerage services	Finance
BenevolentAI SA BenevolentAI SA Packaged SoftwareTechnology Services Develops AI drug discovery platform to accelerate biopharma drug discovery	Technology Services